Laserfiche WebLink
A\. <br />Ar~eric~n Water Works <br />ASSOCIatlOrl <br />The Authoritative Resource on Safe Wafer ~ <br />Utility Member Benefit <br />Government Affairs Office <br />1300 Eye street NW <br />Suite 701 W <br />Washington, DC 200D5 <br />T 202.628.8303 <br />F 202.628.2846 <br />Headquarters <br />6666 West Quincy Avenue <br />Denver, CO Sf}235-3098 <br />Washington, DC 20005 <br />T 303.794.7711 <br />F 303.795.1989 <br />www.awwa.org <br />Public Affairs Advisory <br />TO: AWWA Leadership <br />All Utilities <br />FROM: AWWA Puhlic Affairs <br />DATE: March 7, 2008 <br />Who: Associated Press <br />What: Three-part series on pharmaceuticaislpersonal care products in <br />drinking water and the environment <br />When: Monday, March 90, through Wednesday, March 12 <br />AWWA has received more detailed information on the Associated Press national investigative <br />news story, which is expected to be published as a three-part series on Monday, Tuesday and <br />Wednesday of next week. <br />The series will be divided into three parts: <br />• Part 1 will be an overview an the pharmaceuticals found in water supplies. <br />Sidebars to the story will include the scien#ific research, a major city that found <br />pharmaceuticals in its watershed but did not test its water, and list of 24 cities <br />where drugs where found in the water. <br />• Part 2 will focus on the effects on aquatic animals and other wildlife. An <br />accompanying sidebar wild look at whether or not results are publicly shared. <br />• Part 3 wilt look at the national approach to dealing with pharmaceuticals, pointing <br />out there are no requirements for utilities to monitor for such substances or <br />inform the public. A sidebar will look at how water and wastewater can be <br />treated. <br />The series will be distributed with accompanying photos, graphics, multimedia and video. <br />Abridged versions of all three parts will also be transmitted. <br />AWWA recommends that water utilities contact local media who are likely to cover the <br />story and offer to share information IN ADVANCE OF PUBLICATION. This approach may <br />help prevent undue alarm or misunderstandings. This is especially important if your <br />utility was contacted by AP or has done any testing on pharmaceuticals. <br />